Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00498446 · ClinicalTrials.gov registry record
Magnetic Resonance Imaging of Atrial Septal Defects
A clinical trial, sponsored by Duke University.
- Completed
- Registry status
- 44
- Enrollment target
NCT00498446 is a clinical trial that has completed, run by Duke University. The registered enrollment target is 44 participants.
The verdict
NCT00498446 has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- 44 participants
- Enrollment target
Study Summary
An atrial septal defect (ASD) is a hole in the heart that can lead to heart failure. Depending on the size and severity of the ASD, They can be treated during a heart catheterization with a special device that can permanently seal the ASD, but knowing the exact size and severity of the ASD is crucial. Newer MRI techniques may provide a better way at diagnosing the size and severity of an ASD. We compared MRI to other standard clinical ways for evaluating an ASD.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 44 participants |
| Start Date | 2002-07 |
| Est. Completion | 2004-07 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00498446
The ClinicalTrials.gov registry entry for NCT00498446 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 44 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00498446 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00498446 about?
NCT00498446 is a clinical study titled "Magnetic Resonance Imaging of Atrial Septal Defects". An atrial septal defect (ASD) is a hole in the heart that can lead to heart failure. Depending on the size and severity of the ASD, They can be treated during a heart catheterization with a special device that can permanently seal the ASD, but knowing the exact size and severity of the ASD is crucia...
What is the current status of trial NCT00498446?
This trial is currently completed. The enrollment target is 44 participants. The study started on 2002-07. Estimated completion is 2004-07.
Who is sponsoring clinical trial NCT00498446?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.